Skye Bioscience, Inc PREM14A, filed Oct 26, 2026
Skye Bioscience, Inc. (SKYE)
Skye Bioscience proposes acquiring Redx Pharma Limited, renaming the combined company Fibrx Therapeutics, Inc., and seeking stockholder approval for related share issuances, financing, charter amendments, compensation and meeting adjournment. AI summary
PREM14A
2026-10-26
For: 2026-10-26
View Original
Added on
October 26, 2026